[{"NetIncomeLoss_1_Q1_USD":-71639000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":249427000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":26201000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1432457000.0,"Liabilities_0_Q1_USD":431700000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":0.0,"OperatingLeaseLiability_0_Q1_USD":30673000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":13925000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":27101000.0,"DerivativeLiabilitiesCurrent_0_Q1_USD":3140000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":87384000.0,"OperatingCostsAndExpenses_1_Q1_USD":83311000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":3445000.0,"OtherAssetsNoncurrent_0_Q1_USD":1729000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-38420000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":6952000.0,"AssetsCurrent_0_Q1_USD":406427000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-59000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":49005000.0,"ResearchAndDevelopmentInProcess_1_Q1_USD":0.0,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":1258000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":6741000.0,"CommonStockSharesIssued_0_Q1_shares":71411389.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":380652000.0,"Assets_0_Q1_USD":675947000.0,"ShareBasedCompensation_1_Q1_USD":10607000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":28779000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PaymentsForDerivativeInstrumentFinancingActivities_1_Q1_USD":0.0,"CostOfGoodsAndServicesSoldAmortization_1_Q1_USD":2838000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":3500000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-4996000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-71639000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1132000.0,"ShortTermInvestments_0_Q1_USD":137386000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":5888000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":395000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":27251000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":41362000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":10697000.0,"EarningsPerShareBasic_1_Q1_USD":-1.08,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":13925000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":66636830.0,"PurchaseObligationDueInSecondYear_0_Q1_USD":30000000.0,"NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_1_Q1_USD":213000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-105000.0,"AccountsReceivableNetCurrent_0_Q1_USD":5186000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"PurchaseObligationDueInNextTwelveMonths_0_Q1_USD":30000000.0,"NumberOfReportableSegments_1_Q1_segment":2.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-71639000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-247000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":386800000.0,"InvestmentIncomeNonoperating_1_Q1_USD":97000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":153000.0,"StockIssuedDuringPeriodSharesNewIssues_0_Q1_shares":0.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":21706000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":29044000.0,"NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_1_Q1_USD":0.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":78534000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":4241000.0,"InterestPayableCurrent_0_Q1_USD":629000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":71000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":31000000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":6052000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":10689000.0,"CommonStockSharesOutstanding_0_Q1_shares":71411389.0,"EarningsPerShareDiluted_1_Q1_USD":-1.08,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":3267000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":0.0,"AmortizationOfFinancingCosts_1_Q1_USD":310000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":8137000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":20225000.0,"Goodwill_0_Q1_USD":146964000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":3645000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-74755000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":66636830.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":6613000.0,"LiabilitiesCurrent_0_Q1_USD":50838000.0,"AccountsPayableCurrent_0_Q1_USD":7079000.0,"ProceedsFromConvertibleDebt_1_Q1_USD":0.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":252872000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":8799000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":11136000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2213000.0,"InterestExpenseDebt_1_Q1_USD":1568000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.114,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":-71639000.0,"OtherIntangibleAssetsNet_0_Q1_USD":67837000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":51637000.0,"OperatingLeasePayments_1_Q1_USD":1761000.0,"IncomeLossAttributableToParent_1_Q1_USD":-71639000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":20766000.0,"InterestExpense_1_Q1_USD":1560000.0,"SeniorLongTermNotes_0_Q1_USD":279694000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":3357000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-84131000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":7165000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":3006000.0,"CommonStockSharesAuthorized_0_Q1_shares":95000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":13299000.0,"OperatingIncomeLoss_1_Q1_USD":-70012000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"InventoryNet_0_Q1_USD":5629000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":9046000.0,"PreferredStockValue_0_Q1_USD":0.0,"OperatingLeaseCost_1_Q1_USD":1704000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":675947000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":13940000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":10607000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":0.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":40991000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":4472000.0,"LeaseCost_1_Q1_USD":1987000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1188281000.0,"VariableLeaseCost_1_Q1_USD":283000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":310000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_1_Q1_USD":53000000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":55000.0,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":325900000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":67837000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":4036000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":74967000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":8000000.0,"StockholdersEquity_0_Q1_USD":244247000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-5582000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":10477000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":380652000.0,"PurchaseObligationDueInThirdYear_0_Q1_USD":30000000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]